Watson Laboratories (WPI) issues a voluntary recall for two lots of Hydrocodone Bitartrate and...
Watson Laboratories (WPI) issues a voluntary recall for two lots of Hydrocodone Bitartrate and APAP Tablets, saying it's possible that some tablets exceed the weight specification and may contain higher than indicated amounts of the ingredients Hydrocodone Bitartrate and/or Acetaminophen. The recall was initiated after a customer complaint was received for tablets that were thicker and darker shade than the other tablets.
From other sites
Video at CNBC.com (Jul 27, 2015)
at CNBC.com (Feb 18, 2015)
at CNBC.com (Feb 10, 2015)
at CNBC.com (Feb 5, 2015)
at CNBC.com (Jan 30, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs